Insider Transactions in Q4 2022 at Therapeutics Md, Inc. (TXMD)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 30
2022
|
Rubric Capital Management LP Director |
SELL
Open market or private sale
|
Indirect |
29,000
-100.0%
|
$38,657,000
$1333.0 P/Share
|
Dec 09
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
14,825
+0.84%
|
$88,950
$6.09 P/Share
|
Dec 09
2022
|
Brian Bernick Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
320
-7.63%
|
$1,920
$6.31 P/Share
|
Dec 08
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
300
+0.02%
|
$1,500
$5.83 P/Share
|
Dec 07
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
20,113
+1.14%
|
$100,565
$5.66 P/Share
|
Dec 07
2022
|
Gail K Naughton Director |
SELL
Open market or private sale
|
Direct |
3,922
-100.0%
|
$19,610
$5.26 P/Share
|
Dec 06
2022
|
Marlan D Walker Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,048
-13.55%
|
$4,192
$4.95 P/Share
|
Dec 06
2022
|
Marlan D Walker Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,554
+10.8%
|
-
|
Dec 06
2022
|
Mark A Glickman Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
440
-25.37%
|
$1,760
$4.92 P/Share
|
Dec 06
2022
|
Mark A Glickman Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,734
+50.0%
|
-
|
Dec 06
2022
|
Michael C Donegan Prin. Fin. and Acctg. Officer |
SELL
Open market or private sale
|
Direct |
910
-16.65%
|
$3,640
$4.78 P/Share
|
Dec 06
2022
|
Michael C Donegan Prin. Fin. and Acctg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,476
+14.08%
|
-
|
Dec 06
2022
|
Brian Bernick Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
935
-18.24%
|
$3,740
$4.92 P/Share
|
Dec 06
2022
|
Brian Bernick Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,167
+38.18%
|
-
|
Oct 28
2022
|
Rubric Capital Management LP Director |
BUY
Open market or private purchase
|
Indirect |
7,000
+19.44%
|
$7,000,000
$1000.0 P/Share
|